Induction of antitumor immune responses with recombinant lentivector

Role of skin derived DCs

Qifeng Zhou, Yukai He

Research output: Contribution to journalReview article

Abstract

T cell immune responses play a critical role in preventing and treating malignant tumors. The most effective way for stimulating potent T cell immunity is by genetic immunization with recombinant viral vectors. Recombinant lentivector has recently been studied as antigen delivery vehicle for stimulating potent T cell responses. Studies showed that lentivector immunization can induce remarkably potent and durable CD8 T cell responses possibly because of their high efficiency of transducing dendritic cells (DCs) and persistent antigen presentation. In this brief review, we summarized the recent findings on the basic mechanistic studies, especially on the role of DC subsets in lentivector immunization, and the potential applications of using lentivector immunization for tumor immunotherapy in preclinical animal models.

Original languageEnglish (US)
Pages (from-to)261-266
Number of pages6
JournalCurrent Cancer Therapy Reviews
Volume7
Issue number4
DOIs
StatePublished - Nov 1 2011

Fingerprint

Langerhans Cells
Immunization
T-Lymphocytes
Dendritic Cells
Antigen Presentation
Immunotherapy
Immunity
Neoplasms
Animal Models
Antigens

Keywords

  • Dendritic cells
  • Genetic immunization
  • Recombinant lentivector
  • Tumor immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Molecular Medicine

Cite this

Induction of antitumor immune responses with recombinant lentivector : Role of skin derived DCs. / Zhou, Qifeng; He, Yukai.

In: Current Cancer Therapy Reviews, Vol. 7, No. 4, 01.11.2011, p. 261-266.

Research output: Contribution to journalReview article

@article{00419a31f9524bce826b656661cd3ae1,
title = "Induction of antitumor immune responses with recombinant lentivector: Role of skin derived DCs",
abstract = "T cell immune responses play a critical role in preventing and treating malignant tumors. The most effective way for stimulating potent T cell immunity is by genetic immunization with recombinant viral vectors. Recombinant lentivector has recently been studied as antigen delivery vehicle for stimulating potent T cell responses. Studies showed that lentivector immunization can induce remarkably potent and durable CD8 T cell responses possibly because of their high efficiency of transducing dendritic cells (DCs) and persistent antigen presentation. In this brief review, we summarized the recent findings on the basic mechanistic studies, especially on the role of DC subsets in lentivector immunization, and the potential applications of using lentivector immunization for tumor immunotherapy in preclinical animal models.",
keywords = "Dendritic cells, Genetic immunization, Recombinant lentivector, Tumor immunotherapy",
author = "Qifeng Zhou and Yukai He",
year = "2011",
month = "11",
day = "1",
doi = "10.2174/157339411797642588",
language = "English (US)",
volume = "7",
pages = "261--266",
journal = "Current Cancer Therapy Reviews",
issn = "1573-3947",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Induction of antitumor immune responses with recombinant lentivector

T2 - Role of skin derived DCs

AU - Zhou, Qifeng

AU - He, Yukai

PY - 2011/11/1

Y1 - 2011/11/1

N2 - T cell immune responses play a critical role in preventing and treating malignant tumors. The most effective way for stimulating potent T cell immunity is by genetic immunization with recombinant viral vectors. Recombinant lentivector has recently been studied as antigen delivery vehicle for stimulating potent T cell responses. Studies showed that lentivector immunization can induce remarkably potent and durable CD8 T cell responses possibly because of their high efficiency of transducing dendritic cells (DCs) and persistent antigen presentation. In this brief review, we summarized the recent findings on the basic mechanistic studies, especially on the role of DC subsets in lentivector immunization, and the potential applications of using lentivector immunization for tumor immunotherapy in preclinical animal models.

AB - T cell immune responses play a critical role in preventing and treating malignant tumors. The most effective way for stimulating potent T cell immunity is by genetic immunization with recombinant viral vectors. Recombinant lentivector has recently been studied as antigen delivery vehicle for stimulating potent T cell responses. Studies showed that lentivector immunization can induce remarkably potent and durable CD8 T cell responses possibly because of their high efficiency of transducing dendritic cells (DCs) and persistent antigen presentation. In this brief review, we summarized the recent findings on the basic mechanistic studies, especially on the role of DC subsets in lentivector immunization, and the potential applications of using lentivector immunization for tumor immunotherapy in preclinical animal models.

KW - Dendritic cells

KW - Genetic immunization

KW - Recombinant lentivector

KW - Tumor immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=80054081419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054081419&partnerID=8YFLogxK

U2 - 10.2174/157339411797642588

DO - 10.2174/157339411797642588

M3 - Review article

VL - 7

SP - 261

EP - 266

JO - Current Cancer Therapy Reviews

JF - Current Cancer Therapy Reviews

SN - 1573-3947

IS - 4

ER -